Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive Impairment: A Systematic Review and Meta-analysis

Yue Leng, Claire T McEvoy, Isabel E Allen, Kristine Yaffe, Yue Leng, Claire T McEvoy, Isabel E Allen, Kristine Yaffe

Abstract

Importance: Growing evidence suggests an association between sleep-disordered breathing (SDB) and cognitive decline in elderly persons. However, results from population-based studies have been conflicting, possibly owing to different methods to assess SDB or cognitive domains, making it difficult to draw conclusions on this association.

Objective: To provide a quantitative synthesis of population-based studies on the relationship between SDB and risk of cognitive impairment.

Data sources: PubMed, EMBASE, and PsychINFO were systematically searched to identify peer-reviewed articles published in English before January 2017 that reported on the association between SDB and cognitive function.

Study selection: We included cross-sectional and prospective studies with at least 200 participants with a mean participant age of 40 years or older.

Data extraction and synthesis: Data were extracted independently by 2 investigators. We extracted and pooled adjusted risk ratios from prospective studies and standard mean differences from cross-sectional studies, using random-effect models. This meta-analysis followed the PRISMA guidelines and also adhered to the MOOSE guidelines.

Main outcomes and measures: Cognitive outcomes were based on standard tests or diagnosis of cognitive impairment. Sleep-disordered breathing was ascertained by apnea-hypopnea index or clinical diagnosis.

Results: We included 14 studies, 6 of which were prospective, covering a total of 4 288 419 men and women. Pooled analysis of the 6 prospective studies indicated that those with SDB were 26% (risk ratio, 1.26; 95% CI, 1.05-1.50) more likely to develop cognitive impairment, with no evidence of publication bias but significant heterogeneity between studies. After removing 1 study that introduced significant heterogeneity, the pooled risk ratio was 1.35 (95% CI, 1.11-1.65). Pooled analysis of the 7 cross-sectional studies suggested that those with SDB had slightly worse executive function (standard mean difference, -0.05; 95% CI, -0.09 to 0.00), with no evidence of heterogeneity or publication bias. Sleep-disordered breathing was not associated with global cognition or memory.

Conclusions and relevance: Sleep-disordered breathing is associated with an increased risk of cognitive impairment and a small worsening in executive function. Further studies are required to determine the mechanisms linking these common conditions and whether treatment of SDB might reduce risk of cognitive impairment.

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.. Forest Plot of Prospective Studies…
Figure 1.. Forest Plot of Prospective Studies on Association Between Sleep-Disordered Breathing and Risk of Cognitive Impairment
All effect estimates were pooled using a weighted random-effects model. Heterogeneity: Τ2 = 0.02; χ2 = 11.40; df = 5;P = .04;I2 = 56%. Test for overall effect: z = 2.51; P = .01. Error bars indicate 95% CIs. OR indicates odds ratio.
Figure 2.. Forest Plot of Cross-sectional Studies…
Figure 2.. Forest Plot of Cross-sectional Studies on Association Between Sleep-Disordered Breathing and Cognitive Domains
All effect estimates were pooled using a weighted random-effects model. Error bars indicate 95% CIs. SMD indicates standard mean difference. A, Forest plot of association between sleep-disordered breathing and global cognition. Heterogeneity: Τ2 = 0.00; χ2 = 13.35;df = 5; P = .02;I2 = 63%. Test for overall effect: z = 0.59; P = .56. B, Forest plot of association between sleep-disordered breathing and executive function. Heterogeneity: Τ2 = 0.00; χ2 = 9.00; df = 6;P = .17;I2 = 33%. Test for overall effect: z = 1.92; P = .05. C, Forest plot of association between sleep-disordered breathing and delayed memory. Heterogeneity: Τ2 = 0.00; χ2 = 2.34;df = 4; P = .67;I2 = 0%. Test for overall effect: z = 0.37; P = .71.

Source: PubMed

3
Suscribir